Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-018-33238-9
PubMed Identifier: 30291282
Publication URI: http://europepmc.org/abstract/MED/30291282
Type: Journal Article/Review
Volume: 8
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322